Memo Therapeutics
- Biotech or pharma, therapeutic R&D
Memo Therapeutics has a best-in-class antibody discovery engine and its lead antibody against the BK virus important in kidney transplantation is in pivotal phase II/III to address a non-served >USD1.5bn market
Address
SchlierenZürich-Schlieren
Switzerland
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}